A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

The Oral Proteins And Peptides market report covers market characteristics, size and growth, segmentation, regional and ...

Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the ...

The startup is developing macrocyles, which share strengths of both small molecules and biologics, as oral medicines against ...

Weight-loss medication like Semaglutide and Tirzepatide has seen a rise in demand, causing a boom in sales. This exploding ...

First-in-Human Study Provides Evidence that Sana’s Hypoimmune (HIP) Technology Enables Transplanted Islet Cells to Avoid Immune Rejection and Produce Insulin Without Immunosuppression Results ...

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...

Toll-like receptors (TLRs) are vital components of the immune system, acting as sentinels that detect and respond to ...

Type 2 diabetes is a chronic condition that affects the body’s ability to regulate blood sugar levels. For many patients, ...

Jeremy Renner said he is feeling "strong" and "blessed" two years after he was seriously injured in a near-fatal snowplow accident.